Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Neutral

AI Analysis

Summary

Madrigal Pharmaceuticals granted equity inducement awards to 13 new non-executive employees on August 15, 2026, under its 2025 Inducement Plan, approved by the Compensation Committee in accordance with Nasdaq Listing Rule 5635(c)(4).

Importance:1/10

Sentiment:

0.00

equity awardsinducementNasdaq Listing Ruleemployee compensationnon-executive

Related Companies

$MDGL

Read the original article

Published by GlobeNewswire Pharma on August 20, 2026 8:05 PM

Read Original